An Open Access Journal
2023 Impact Factor: 1.1
2023 CiteScore: 1.9
ISSN: 2717-3593
Research
not a Cost, but an Investment
Editor-in-Chief:
Mohammad Jalili, MD
Chairman:
Hooman Hossein-Nejad, MD
Aim of peer review process
Peer review is a process to improve the quality of the material that is due to be eventually published in a scientific journal. Frontiers in Emergency Medicine appreciates gratefully the time and effort reviewers invest in this process.
Our journal policy dictates us to be ensured that peer review is definitely unbiased, fair and accurate. Decision to whether accept or decline a manuscript for publication depends on the novelty of the topic, its importance and originality, validity and reliability of the study and of course its relevance to the scope of the journal.
We use different academic sources to identify most qualified and dedicated reviewers. It should be emphasized that reviewers’ evaluations and comments play a major role in our decision to choose the best and most informative articles for publication.
FEM committedly conducts a double-blind review process in which the identities of both authors and reviewers are hidden from each other.
General notes
Comments to the editor
Any possible conflicts of interest can be submitted to the Editor-in-Chief.
Comments to the author
All comments and criticism of the manuscript should only be placed in the “Comments to the Author”. They will be submitted to the associate editors and the editor-in-chief. Communication to the authors and reviewers will be kept on until the final decision has been made by the editor-in-chief.
Comments should be effective, productive, useful, constructive and designed to enhance the manuscript. Make your comments as clear, complete and detailed as possible. Express your viewpoints with supporting statements. Begin with the major contributions of the paper. Include the strengths of the work besides its weaknesses. Emphasize on its originality and relevance to the field. Mention both general and specific points, both major and minor concerns. Support your comments with specific evidence and necessary references.
Points to be considered in your review include:
An Open Access Journal
2023 Impact Factor: 1.1
2023 CiteScore: 1.9
ISSN: 2717-3593
Research
not a Cost, but an Investment
Editor-in-Chief:
Mohammad Jalili, MD
Chairman:
Hooman Hossein-Nejad, MD
All the work in this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |